Demand for virtual, augmented and mixed reality tech is growing faster than even bullish analysts thought possible. Here’s how to cash in. Read More
John Persinos is the editorial director of Investing Daily, overseeing such publications as Personal Finance, Utility Forecaster, Profit Catalyst Alert, Rapier's Income Accelerator, Income Forecaster, and Marijuana Investing Daily, among others. John also writes the Mind Over Markets daily stock market recap, and he's the chief investment strategist of Marijuana Profit Alert.
John has decades of experience in the technology and political realms. He has worked as a staff editor at Inc. and Venture magazines, and written for Kiplinger's, Street Authority, Investing Answers, and TheStreet.com, to name a few. In a career that has spanned more than 40 years, John has been diligently and prolifically covering the news and its impact on investors.
John also has experience with the inner-workings of Capitol Hill, serving as a press secretary to U.S. Rep. Byron Dorgan (D-ND). John started his career as a daily newspaperman with The Orlando Sentinel.
John holds undergraduate and graduate degrees from Boston University. He also completed the Davenport Fellowship in Business and Economics Reporting at the University of Missouri (Columbia).
Analyst Articles
We interview a top expert about high-yield stocks, and delve into the ability of this asset class to offer steady growth and income even during market dips. Read More
After a prolonged slump in 2023, marijuana equities have rebounded so far this year and, as a whole, are outpacing the S&P 500. Read More
Federal Reserve Chair Jerome Powell said last week: “Let's be honest, this is a good economy.” We should believe him. Read More
Contrary to popular myth, China is on the downslope and America is ascendant. Here’s a closer look at how the red dragon is losing its fire. Read More
Factors remain in place to sustain the stock market rally, but an undercurrent of caution has crept into trading as risks increase. Read More
Research confirms the power of marijuana in pain management and treating substance abuse. Big Pharma should be worried. Read More
These mega-cap tech stocks account for about 60% of the S&P 500's strong rise over the past 12 months. Can the seven stay in the saddle? Read More
Leverage can be useful, if applied properly. Here’s a look at certain types of loans that are rip-offs. Read More
Jobs growth and tech profits paint a rosy, not red-hot, picture. We parse the latest economic data. Read More